F.D.A. May Move Toward Updating Vaccines
Scientists had high hopes for a new coronavirus vaccine that combines the existing formulation with one targeting Omicron, but many are not impressed by the results.
Stay updated with breaking news from Kellyl Moore. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Scientists had high hopes for a new coronavirus vaccine that combines the existing formulation with one targeting Omicron, but many are not impressed by the results.
Scientists had high hopes for a new coronavirus vaccine that combines the existing formulation with one targeting Omicron, but many are not impressed by the results.
A panel of independent experts advising the FDA is set to recommend whether to update existing COVID-19 vaccines to target a newer version of the coronavirus in a booster shot that Americans could get in the fall.
Feb 2, 2021 Reduced efficacy seen in South African strain Johnson & Johnson’s single-shot Covid-19 vaccine candidate was shown to be very effective overall, but significantly less effective against the highly contagious South African B.1.351 variant of the disease predicted by many to become the dominant form of SARS-CoV-2 infection in the United States by mid-spring. Data from the ENSEMBLE trial, released Friday morning, showed the vaccine to have a 72% overall efficacy in U.S., with a 66% overall effectiveness for preventing moderate-to-severe disease 28 days after vaccination. Trial data...